AES (AES) Stock

Xenon Pharmaceuticals Inc., a biopharmaceutical company focused on neuroscience, has announced that it will present several findings at the American Epilepsy Society Annual Meeting (AES 2024) from December 6-10, 2024, in Los Angeles. They will showcase five posters that include long-term data from the X-TOLE study on azetukalner for patients with focal onset seizures, as well as insights into the mental health challenges associated with these seizures and new pre-clinical data from their Nav1.1 program.

The Trump Trade has led to a major drop in AES Corp.'s stock, overlooking its solid fundamentals and presenting a chance to buy. Even with the possible loss of renewable energy tax credits, AES's varied income streams and move towards renewables provide great potential for growth. Additionally, AES offers a steady dividend yield of 5.21% and has made significant investments in renewable projects supported by long-term agreements, which promise future expansion.

According to Nigel Green, the CEO of deVere Group, the recent drop in renewable energy stocks following Donald Trump's victory in the US presidential election presents a good chance for investors to buy.

AES' earnings for the third quarter exceeded the Zacks Consensus Estimate by 18.3%. On the other hand, its revenues fell short of the consensus estimate by 9.3%.

AES (AES) reported quarterly earnings of $0.71 per share, which is higher than the Zacks Consensus Estimate of $0.60 per share. This is an increase compared to earnings of $0.60 per share from the same period last year.

The AES Corporation has confirmed its guidance for 2024 and long-term growth rates, highlighting significant achievements such as signing 2.2 GW of new contracts and completing the construction of 1.2 GW. Financial results for Q3 2024 show a diluted EPS of $0.72 and a net income of $210 million. The company expects to meet its adjusted EPS and EBITDA targets for 2024, despite some challenges from extreme weather and lower margins.

AES (AES) has the right mix of factors that could lead to a strong earnings report soon. Be ready for the important expectations.

AES has a strong track record of surprising with its earnings and currently has the right mix of factors that suggest it may exceed expectations in its upcoming quarterly report.

Dividends are one of the biggest advantages of being a shareholder, but it can be challenging to identify a good dividend stock. Does AES (AES) meet the criteria?